KOD

Kodiak Sciences Inc

2.61 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Kodiak Sciences Inc stock is down -19.94% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 5 June’s closed higher than May.

About Kodiak Sciences Inc

Kodiak Sciences Inc. researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD) The company was formerly known as Oligasis, LLC.